BRIDGEBIO PHARMA INC
BBIO·10806X102·US·Common Stock·Healthcare - Biotechnology-Activist
BBIO (BRIDGEBIO PHARMA INC) is held by 201 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), Janus Henderson Group Ltd. ($978.6M), VIKING GLOBAL INVESTORS LP ($879.4M). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 121 funds bought BBIO.
201
Holders
(40 Elite)
$11.7B
Total Value
60% (202)
Consensus
121 buying - 81 selling
13F: Insider & Congress:
Who's Trading
InsiderCECook Jennifer E.Sell $3.0MJul 9, 2026
InsiderEAEllis AndreaSell $1.4MJul 9, 2026
InsiderCECook Jennifer E.Sell $10.1MJul 9, 2026
ActivistDJDapice Joshua J.5.2%May 29, 2026
InsiderKNKumar NeilSell $152KMay 21, 2026
Showing 1-20 of 215
1 / 11
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer